# Matthias Endres

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matthias-endres/

## Facts

| Field | Value |
| --- | --- |
| Citations | 97,551 |
| Field | Acute Ischemic Stroke Management |
| h-index | 111 |
| i10-index | 510 |
| Last Known Institution | German Center for Neurodegenerative Diseases |
| OpenAlex ID | https://openalex.org/A5001101402 |
| ORCID iD | https://orcid.org/0000-0001-6520-3720 |
| Works | 984 |

## Researcher papers

- [Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016](https://scholariq.org/papers/global-regional-and-national-burden-of-stroke-1990-2016-a-systematic-analysis/)
- [Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016](https://scholariq.org/papers/global-regional-and-national-burden-of-parkinson-s-disease-1990-2016-a/)
- [Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016](https://scholariq.org/papers/global-regional-and-national-burden-of-alzheimer-s-disease-and-other-dementias/)
- [Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source](https://scholariq.org/papers/rivaroxaban-for-stroke-prevention-after-embolic-stroke-of-undetermined-source/)
- [Stroke genetics informs drug discovery and risk prediction across ancestries](https://scholariq.org/papers/stroke-genetics-informs-drug-discovery-and-risk-prediction-across-ancestries/)
- [Leitlinien für Diagnostik und Therapie in der Neurologie](https://scholariq.org/papers/leitlinien-fur-diagnostik-und-therapie-in-der-neurologie/)
- [The state of stroke services across the globe: Report of World Stroke Organization–World Health Organization surveys](https://scholariq.org/papers/the-state-of-stroke-services-across-the-globe-report-of-world-stroke/)
- [Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data](https://scholariq.org/papers/intravenous-alteplase-for-stroke-with-unknown-time-of-onset-guided-by-advanced/)
- [Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial](https://scholariq.org/papers/rivaroxaban-or-aspirin-for-patent-foramen-ovale-and-embolic-stroke-of/)

## Researcher topics

- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Stroke Rehabilitation and Recovery](https://scholariq.org/topics/stroke-rehabilitation-and-recovery/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Researcher university

- [German Center for Neurodegenerative Diseases](https://scholariq.org/institutions/german-center-for-neurodegenerative-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.